EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR

Overview Fund Activity
Delisted

EUCR was delisted on the 26th of April, 2023.

Back to rankings

5 hedge funds and large institutions have $9.91M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$4.02M
2
GPCM
Granite Point Capital Management
Massachusetts
+$3.85M
3
SCM
Suvretta Capital Management
New York
+$1.01M
4
RCM
Radcliffe Capital Management
Pennsylvania
+$1.01M
5
WAM
Wolverine Asset Management
Illinois
+$30K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$4.02M +$4.02M +399,999 New
GPCM
2
Granite Point Capital Management
Massachusetts
$3.85M +$3.85M +382,693 New
SCM
3
Suvretta Capital Management
New York
$1.01M +$1.01M +99,999 New
RCM
4
Radcliffe Capital Management
Pennsylvania
$1.01M +$1.01M +100,000 New
WAM
5
Wolverine Asset Management
Illinois
$30K +$30K +3,000 New